Vildax M 50/500mg Tablet

VILDAX M 50/500MG Tablet is a fixed-dose combination oral antidiabetic medication containing:

• Metformin 500 mg: A biguanide that reduces hepatic glucose production and improves insulin sensitivity, helping to lower blood glucose levels.

• Vildagliptin 50 mg: A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that increases incretin hormones, enhancing insulin secretion and reducing glucagon levels in a glucose-dependent manner.

This combination provides a complementary effect to improve glycemic control in adults with Type 2 Diabetes Mellitus (T2DM).

USES

• Management of Type 2 Diabetes Mellitus when monotherapy is insufficient

• Adjunct to diet and exercise to improve blood sugar control

• Used in patients requiring combination therapy for optimal glycemic management

BENEFITS

• Dual mechanism of action: decreases glucose production and increases insulin secretion

• Helps achieve better blood sugar control with fewer side effects

• Low risk of hypoglycemia when used appropriately

• Weight neutral or may aid in modest weight loss

• Convenient fixed-dose tablet for improved patient adherence

SIDE EFFECTS

Common Side Effects:

• Gastrointestinal symptoms like nausea, diarrhea, and abdominal discomfort (mainly due to Metformin)

• Headache

• Dizziness

• Nasopharyngitis

Serious or Rare Side Effects:

• Lactic acidosis (rare, associated with Metformin)

• Pancreatitis (rare, associated with Vildagliptin)

• Hypersensitivity reactions (rash, swelling)

• Hypoglycemia, especially when combined with other antidiabetic drugs